Cellectar Biosciences, Inc. — Director's Dealing 2020

Jun 25, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Cellectar Biosciences, Inc. (CLRB)
CIK: 0001279704
Period of Report: 2020-06-24

Reporting Person: NEIS JOHN (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-06-24	Stock option (right to buy)	$1.28	A	50000	Acquired	2030-06-24	Common Stock (50000)	Direct

Footnotes

F1: This option grant shall vest over a period of three years from the grant date, with one-third vesting on the first anniversary of the grant date and the remainder vesting in 24 equal monthly installments over a 24 month period beginning on the first anniversary of the grant date.